economics

Cancer Treatment Dollars and Sense

July 18, 2011

In a typical clinical trial, the results are reported in purely medical or biological terms. Did the patients in the treatment group live longer than those in the control group? Did the drug shrink the tumor or reduce symptoms? Were clinical [Read more]

The Personalized Medicine Bargain

February 7, 2011

The future of medicine, we are told time and time again, is genetic and personalized. Someday, physicians will call up the genetic code of a patient and determine their genetic risks and which treatments will work most effectively with the fewest [Read more]

The Off-Label Antipsychotic Surge

January 20, 2011

If you watch enough football games, you might come away with the impression that today’s most profitable drugs are for erectile dysfunction, cholesterol, and allergies. But far less public attention is paid to one of the most expensive classes [Read more]